10-Q: Q1 2024 Earnings Report
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Ocean Biomedical Receives Nasdaq Non-Compliance Notice For Minimum Bid Price
10-K: FY2023 Annual Report
Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report
12 Health Care Stocks Moving In Thursday's After-Market Session
Express News | Ocean Biomedical Inc - Elizabeth Ng to Take a Sabbatical for Personal Reason
Express News | Ocean Biomedical Inc - Michelle Berrey to Act as Interim Chief Executive Officer
Express News | Ocean Biomedical- Ownership in Virion to Equal 22% of Virion's Issued & Outstanding Membership Interests, in Exchange for $9 Mln
Express News | Ocean Biomedical- Ratified Fully Countersigned Copy of Revised Agreement With Virion Therapeutics Received on Sept 26
Ocean Biomedical, Molecure Sign Licensing Agreement for YKL-40 Inhibitors
Molecure (WSE: MOC) and Nasdaq-listed Biotechnology Company Ocean Biomedical (NASDAQ: OCEA) Sign an Exclusive Licensing Agreement for the Development and Commercialization of Selective YKL-40 Inhibitors.
Ocean Biomedical's Oncology Platform Included in New Published Study
Ocean Biomedical Announces Publication Of New Data Deepening Understanding Of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 And Its Ability To Inhibit Anti-Tumor And Related Tissue Remodeling Responses
Express News | Ocean Biomedical's Scientific Co-founder Jonathan Kurtis Issued US Patent For PfGARP Malaria Antibody
Express News | Ocean Biomedical Received Noncompliance Notice From Nasdaq
12 Health Care Stocks Moving In Monday's After-Market Session
Express News | Ocean Biomedical Receives Notice From Nasdaq That It Is Not In Compliance With Listing Rule
Express News | Ocean Biomedical, Inc. Announces Receipt of Notice From Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
Express News | Ocean Biomedical Granted Patent Allowance For Malaria Antibodies